No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Nectar Lifesciences Ltd. operates as a pharmaceutical company, involved in the manufacturing and sale of medicinal products across India and globally. Its product portfolio includes a range of active pharmaceutical ingredients (APIs) and intermediate compounds. These notably feature various cephalosporins such as cefixime, cefuroxime axetil (both amorphous and crystalline forms), cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefpodoxime proxetil (including sterile variants), cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime + Arginine. The company further provides contract manufacturing services for completed dosage forms. These encompass a variety of pharmaceutical presentations like tablets, capsules, dry powder oral suspensions, granules, and injectables, specifically tailored for cephalosporin drugs. Beyond pharmaceuticals, Nectar Lifesciences also supplies menthol, its derivatives, and empty hard gelatin capsules. Established in 1995, Nectar Lifesciences Limited maintains its primary operations from its headquarters in Chandigarh, India.
www.neclife.comNo one on the platform currently holds NECLIFE.BO.
No tracked institution reports a position in NECLIFE.BO as of their last filing.
No one on the platform has traded NECLIFE.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| NECLIFE.BONectar Lifesciences Limited | $10.99 | -3.43% | $2.1B | — |
| AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited | $99.94 | +1.13% | $2.8B | — |
| BAFNAPH.NSBafna Pharmaceuticals Limited | $309.00 | +0.55% | $7.3B | — |
| BROOKS.BOBrooks Laboratories Limited | $61.19 | -4.44% | $1.8B | — |
| BROOKS.NSBrooks Laboratories Limited | $61.02 | -3.28% | $1.8B | — |
| UNIVPHOTO.BOUniversus Photo Imagings Ltd | $595.00 | +4.94% | $6.3B | — |
| UNIVPHOTO.NSUniversus Photo Imagings Limited | $595.05 | +4.99% | $6.5B | — |
Source: Financial Modeling Prep · peers by sector/industry